OCULAR THERAPEUTIX, INC - OCUL
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 27, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners III, L.P. | 3.2% | 6,862,972 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | VHCP Co-Investment Holdings III, LLC | 3.2% | 6,862,972 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners EG, L.P. | 3.2% | 6,862,972 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | VHCP Management III, LLC | 3.2% | 6,862,972 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | VHCP Management EG, LLC | 3.2% | 6,862,972 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Nimish Shah | 3.2% | 6,862,972 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Bong Y. Koh | 3.2% | 6,862,972 | View |
| Feb 10, 2026 | SCHEDULE 13G | Deep Track Capital, LP | 5.13% | 11,234,132 | View |
| Feb 10, 2026 | SCHEDULE 13G | Deep Track Biotechnology Master Fund, Ltd. | 5.13% | 11,234,132 | View |
| Feb 10, 2026 | SCHEDULE 13G | David Kroin | 5.13% | 11,234,132 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Deep Track Capital, LP | 4.31% | 9,234,132 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Deep Track Biotechnology Master Fund, Ltd. | 4.31% | 9,234,132 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | David Kroin | 4.31% | 9,234,132 | View |
| Dec 08, 2025 | SCHEDULE 13G | SUMMER ROAD LLC | 5.7% | 12,134,357 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners III, L.P. | 7.3% | 12,913,420 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | VHCP Co-Investment Holdings III, LLC | 7.3% | 12,913,420 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners EG, L.P. | 7.3% | 12,913,420 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | VHCP Management III, LLC | 7.3% | 12,913,420 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | VHCP Management EG, LLC | 7.3% | 12,913,420 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Nimish Shah | 7.3% | 12,913,420 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Bong Y. Koh | 7.3% | 12,913,420 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Deep Track Capital, LP | 6.18% | 13,095,855 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Deep Track Biotechnology Master Fund, Ltd. | 6.18% | 13,095,855 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | David Kroin | 6.18% | 13,095,855 | View |
| Nov 05, 2025 | SCHEDULE 13G/A | FMR LLC | 15.0% | 31,785,634 | View |
| Nov 05, 2025 | SCHEDULE 13G/A | Abigail P. Johnson | 15.0% | 31,785,634 | View |
| Oct 17, 2025 | SCHEDULE 13G/A | BlackRock, Inc. | 5.8% | 10,170,232 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.